{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:21:26Z","timestamp":1790392886170,"version":"4.1.0"},"reference-count":126,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001412","name":"Council of Scientific & Industrial Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalnutritionjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.clnu.2021.04.011","type":"journal-article","created":{"date-parts":[[2021,4,18]],"date-time":"2021-04-18T17:45:08Z","timestamp":1618767908000},"page":"2508-2519","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Beverages and Non-alcoholic fatty liver disease (NAFLD): Think before you drink"],"prefix":"10.1016","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6155-7721","authenticated-orcid":false,"given":"Jyoti","family":"Chhimwal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4912-9871","authenticated-orcid":false,"given":"Vikram","family":"Patial","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1793-9340","authenticated-orcid":false,"given":"Yogendra","family":"Padwad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clnu.2021.04.011_bib1","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.clnu.2021.04.011_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00082","article-title":"The differential roles of T-cells in non-alcoholic fatty liver disease and obsity","volume":"10","author":"Van Herck","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.clnu.2021.04.011_bib3","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1146\/annurev-physiol-021115-105331","article-title":"Pathophysiology and mechanisms of nonalcoholic fatty liver disease","volume":"78","author":"Haas","year":"2016","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.clnu.2021.04.011_bib4","series-title":"The rise in the prevalence of nonalcoholic fatty liver disease and hepatocellular carcinoma. InNonalcoholic fatty liver disease-an update 2019 sep 11","author":"Sherif","year":"2019"},{"key":"10.1016\/j.clnu.2021.04.011_bib5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4103\/ijmr.IJMR_1456_17","article-title":"Non-alcoholic fatty liver disease associated with hepatocellular carcinoma: an increasing concern","volume":"149","author":"Dhamija","year":"2019","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.clnu.2021.04.011_bib6","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0025-6196(24)00530-5","article-title":"Nonalcoholic steatohepatitis. Mayo Clinic experiences with a hitherto unnamed disease","volume":"55","author":"Ludwig","year":"1980","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.clnu.2021.04.011_bib7","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-57369-9","article-title":"Effect of weight change and lifestyle modifications on the development or remission of nonalcoholic fatty liver disease: sex-specific analysis","volume":"10","author":"Yoshioka","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.clnu.2021.04.011_bib8","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.pmedr.2017.11.004","article-title":"Consumption of fast food, sugar-sweetened beverages, artificially-sweetened beverages and allostatic load among young adults","volume":"10","author":"van Draanen","year":"2018","journal-title":"Prev Med Reports"},{"key":"10.1016\/j.clnu.2021.04.011_bib9","doi-asserted-by":"crossref","first-page":"6700","DOI":"10.3390\/nu7085304","article-title":"Beverage consumption: are alcoholic and sugary drinks tipping the balance towards overweight and obesity?","volume":"7","author":"Poppitt","year":"2015","journal-title":"Nutrients"},{"key":"10.1016\/j.clnu.2021.04.011_bib10","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.jhep.2018.01.019","article-title":"Fructose and sugar: a major mediator of non-alcoholic fatty liver disease","volume":"68","author":"Jensen","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.clnu.2021.04.011_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/nu9040405","article-title":"Fructose consumption in the development of obesity and the effects of different protocols of physical exercise on the hepatic metabolism","volume":"9","author":"Pereira","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.clnu.2021.04.011_bib12","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jhep.2017.04.014","article-title":"Coffee and tea breaks for liver health","volume":"67","author":"Petta","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.clnu.2021.04.011_bib13","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1038\/s41395-018-0133-5","article-title":"Type and pattern of alcohol consumption is associated with liver fibrosis in patients with non-alcoholic fatty liver disease","volume":"113","author":"Mitchell","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clnu.2021.04.011_bib14","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-013739","article-title":"Coffee, including caffeinated and decaffeinated coffee, and the risk of hepatocellular carcinoma: a systematic review and dose-response meta-Analysis","volume":"7","author":"Kennedy","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.clnu.2021.04.011_bib15","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1002\/hep.22292","article-title":"Modest wine drinking and decreased prevalence of suspected nonalcoholic fatty liver disease","volume":"47","author":"Dunn","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.clnu.2021.04.011_bib16","doi-asserted-by":"crossref","first-page":"271","DOI":"10.14740\/gr913w","article-title":"Non-alcoholic fatty liver disease in Africa and Middle East: an Attempt to predict the present and future implications on the healthcare system","volume":"10","author":"Ahmed","year":"2017","journal-title":"Gastroenterol Res"},{"key":"10.1016\/j.clnu.2021.04.011_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0173499","article-title":"Prevalence of non-Alcoholic fatty liver disease and risk factors for advanced fibrosis and mortality in the United States","volume":"12","author":"Le","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.clnu.2021.04.011_bib18","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jhep.2016.04.005","article-title":"Non-alcoholic fatty liver disease and cardiovascular risk: pathophysiological mechanisms and implications","volume":"65","author":"Francque","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.clnu.2021.04.011_bib19","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1002\/hep4.1127","article-title":"Targeting bile acids and lipotoxicity for NASH treatment","volume":"1","author":"Chiang","year":"2017","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.clnu.2021.04.011_bib20","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1126\/science.1204265","article-title":"Human fatty liver disease: old questions and new insights","volume":"332","author":"Cohen","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.clnu.2021.04.011_bib21","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI23621","article-title":"Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease","volume":"115","author":"Donnelly","year":"2005","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.clnu.2021.04.011_bib22","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1007\/s00125-005-1682-x","article-title":"Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms","volume":"48","author":"Bugianesi","year":"2005","journal-title":"Diabetologia"},{"key":"10.1016\/j.clnu.2021.04.011_bib23","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/ijo.2012.181","article-title":"Increased insulin receptor substrate 2 expression is associated with steatohepatitis and altered lipid metabolism in obese subjects","volume":"37","author":"Rametta","year":"2013","journal-title":"Int J Obes"},{"key":"10.1016\/j.clnu.2021.04.011_bib24","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/9547613","article-title":"Role of oxidative stress in pathophysiology of nonalcoholic fatty liver disease","author":"Masarone","year":"2018","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.clnu.2021.04.011_bib25","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00281-009-0152-9","article-title":"The immunopathogenesis of alcoholic and nonalcoholic steatohepatitis: two triggers for one disease?","volume":"31","author":"Valenti","year":"2009","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.clnu.2021.04.011_bib26","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1172\/JCI8814","article-title":"CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis","volume":"105","author":"Leclercq","year":"2000","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.clnu.2021.04.011_bib27","doi-asserted-by":"crossref","first-page":"5219","DOI":"10.2174\/13816128113199990381","article-title":"Genetic predisposition in NAFLD and NASH: impact on severity of liver disease and response to treatment","volume":"19","author":"Dongiovanni","year":"2013","journal-title":"Curr Pharmaceut Des"},{"key":"10.1016\/j.clnu.2021.04.011_bib28","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/B978-0-12-815504-2.00007-4","article-title":"Traditional beverages in different countries: milk-based beverages","volume":"9","author":"Sani","year":"2019","journal-title":"Milk-Based Beverages"},{"key":"10.1016\/j.clnu.2021.04.011_bib29","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1467-789X.2007.00389.x","article-title":"A\u00a0short history of beverages and how our body treats them","volume":"9","author":"Wolf","year":"2008","journal-title":"Obes Rev"},{"key":"10.1016\/j.clnu.2021.04.011_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0954422416000202","article-title":"Traditional low-alcoholic and non-alcoholic fermented beverages consumed in European countries: a neglected food group","volume":"30","author":"Baschali","year":"2017","journal-title":"Nutr Res Rev"},{"key":"10.1016\/j.clnu.2021.04.011_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-800270-4.00001-8","article-title":"Antioxidants in food: content, measurement, significance, action, cautions, caveats, and research needs","volume":"71","author":"Benzie","year":"2014","journal-title":"Adv Food Nutr Res"},{"key":"10.1016\/j.clnu.2021.04.011_bib32","series-title":"Faostat","author":"Food and Agriculture Organization of the United Nations","year":"2006"},{"key":"10.1016\/j.clnu.2021.04.011_bib33","article-title":"Demand analysis of non-alcoholic beverages in Japan","volume":"7","author":"Yohannes","year":"2015","journal-title":"J\u00a0Agric Sci"},{"key":"10.1016\/j.clnu.2021.04.011_bib34","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1016\/j.jada.2006.09.009","article-title":"Beverage consumption in the US population","volume":"106","author":"Storey","year":"2006","journal-title":"J\u00a0Am Diet Assoc"},{"key":"10.1016\/j.clnu.2021.04.011_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124845","article-title":"Global, regional, and national consumption of sugar-sweetened beverages, fruit juices, and milk: a systematic assessment of beverage intake in 187 countries","volume":"10","author":"Singh","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.clnu.2021.04.011_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2019.00117","article-title":"Consumption patterns of milk and 100% juice in relation to diet quality and body weight Among United States children: Analyses of NHANES 2011-16 data","volume":"6","author":"Maillot","year":"2019","journal-title":"Front Nutr"},{"key":"10.1016\/j.clnu.2021.04.011_bib37","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.2105\/AJPH.2012.300974","article-title":"Relationship of soft drink consumption to global overweight, obesity, and diabetes: a cross-national analysis of 75 countries","volume":"103","author":"Basu","year":"2013","journal-title":"Am J Publ Health"},{"key":"10.1016\/j.clnu.2021.04.011_bib38","first-page":"38","article-title":"Demand analysis for non-alcoholic beverages consumptin in the United States","volume":"3","author":"Pokharel","year":"2016","journal-title":"Int J Soc Sci Manag"},{"key":"10.1016\/j.clnu.2021.04.011_bib39","series-title":"Global status report on alcohol and health 2018","author":"World Health Organization","year":"2019"},{"key":"10.1016\/j.clnu.2021.04.011_bib40","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/MPG.0000000000001482","volume":"64","author":"Vos","year":"2017","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.clnu.2021.04.011_bib41","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3390\/nu10020157","article-title":"Liver fat scores moderately reflect interventional changes in liver fat content by a low-fat diet but not by a low-carb diet","volume":"10","author":"Kabisch","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.clnu.2021.04.011_bib42","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4291\/wjgp.v8.i2.11","article-title":"Nonalcoholic fatty liver disease: diagnostic biomarkers","volume":"8","author":"Hadizadeh","year":"2017","journal-title":"World J Gastrointest Pathophysiol"},{"key":"10.1016\/j.clnu.2021.04.011_bib43","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.diabet.2016.11.006","article-title":"An extended fatty liver index to predict non-alcoholic fatty liver disease","volume":"43","author":"Kantartzis","year":"2017","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.clnu.2021.04.011_bib44","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.clnu.2021.04.011_bib45","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3945\/ajcn.111.022533","article-title":"Sucrose-sweetened beverages increase fat storage in the liver, muscle, and visceral fat depot: a 6-mo randomized intervention study","volume":"95","author":"Maersk","year":"2012","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.clnu.2021.04.011_bib46","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.jhep.2009.05.033","article-title":"Soft drink consumption is associated with fatty liver disease independent of metabolic syndrome","volume":"51","author":"Abid","year":"2009","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.clnu.2021.04.011_bib47","doi-asserted-by":"crossref","first-page":"26","DOI":"10.7570\/jomes19042","article-title":"Three-Month daily consumption of sugar-Sweetened beverages affects the liver, adipose tissue, and glucose metabolism","volume":"29","author":"Lee","year":"2020","journal-title":"J\u00a0Obes Metab Syndr"},{"key":"10.1016\/j.clnu.2021.04.011_bib48","first-page":"294","article-title":"Adverse effects of dietary fructose","volume":"10","author":"Gaby","year":"2005","journal-title":"Alternative Med Rev"},{"key":"10.1016\/j.clnu.2021.04.011_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2017.00964","article-title":"Lipocalin-2 in fructose-induced fatty liver disease","volume":"8","author":"Lambertz","year":"2017","journal-title":"Front Physiol"},{"key":"10.1016\/j.clnu.2021.04.011_bib50","article-title":"Fructose and NAFLD: the multifaceted aspects of fructose metabolism","volume":"9","author":"Jegatheesan","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.clnu.2021.04.011_bib51","first-page":"1","article-title":"Endogenous fructose production and metabolism in the liver contributes to the development of metabolic syndrome","volume":"4","author":"Lanaspa","year":"2013","journal-title":"Nat Commun"},{"key":"10.1016\/j.clnu.2021.04.011_bib52","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.jhep.2007.06.020","article-title":"Long term nutritional intake and the risk for non-alcoholic fatty liver disease (NAFLD): a population based study","volume":"47","author":"Zelber-Sagi","year":"2007","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.clnu.2021.04.011_bib53","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.jhep.2015.03.032","article-title":"Sugar-sweetened beverage, diet soda, and fatty liver disease in the Framingham Heart Study cohorts","volume":"63","author":"Ma","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.clnu.2021.04.011_bib54","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.jada.2007.03.004","article-title":"Regular sugar-sweetened beverage consumption between meals increases risk of overweight among preschool-aged children{A figure is presented}","volume":"107","author":"Dubois","year":"2007","journal-title":"J\u00a0Am Diet Assoc"},{"key":"10.1016\/j.clnu.2021.04.011_bib55","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.jhep.2008.02.011","article-title":"Fructose consumption as a risk factor for non-alcoholic fatty liver disease","volume":"48","author":"Ouyang","year":"2008","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.clnu.2021.04.011_bib56","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1002\/hep.23535","article-title":"Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease","volume":"51","author":"Abdelmalek","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.clnu.2021.04.011_bib57","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/ejcn.2015.95","article-title":"Consumption of sucrose-sweetened soft drinks increases plasma levels of uric acid in overweight and obese subjects: a 6-month randomised controlled trial","volume":"69","author":"Bruun","year":"2015","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.clnu.2021.04.011_bib58","doi-asserted-by":"crossref","first-page":"727","DOI":"10.3945\/ajcn.112.038695","article-title":"Effect of short-term carbohydrate overfeeding and long-term weight loss on liver fat in overweight humans","volume":"96","author":"Sevastianova","year":"2012","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.clnu.2021.04.011_bib59","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/ajcn\/nqaa332","article-title":"Effects of fructose restriction on liver steatosis (FRUITLESS); a double-blind randomized controlled trial","volume":"113","author":"Simons","year":"2021","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.clnu.2021.04.011_bib60","doi-asserted-by":"crossref","DOI":"10.3390\/biom9100601","article-title":"Allopurinol prevents the lipogenic response induced by an acute oral fructose challenge in short-term fructose fed rats","volume":"9","author":"Garc\u00eda-Arroyo","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.clnu.2021.04.011_bib61","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1093\/ajcn\/74.6.737","article-title":"De novo lipogenesis during controlled overfeeding with sucrose or glucose in lean and obese women","volume":"74","author":"McDevitt","year":"2001","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.clnu.2021.04.011_bib62","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.fct.2013.10.042","article-title":"Beverage caffeine intakes in the U.S","volume":"63","author":"Mitchell","year":"2014","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.clnu.2021.04.011_bib63","doi-asserted-by":"crossref","first-page":"569","DOI":"10.2337\/dc13-1203","article-title":"Caffeinated and decaffeinated coffee consumption and risk of type 2 diabetes: a systematicreview and a dose-response meta-analysis","volume":"37","author":"Ding","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clnu.2021.04.011_bib64","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1039\/C7FO00388A","article-title":"How coffee affects metabolic syndrome and its components","volume":"8","author":"Baspinar","year":"2017","journal-title":"Food Funct"},{"key":"10.1016\/j.clnu.2021.04.011_bib65","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.numecd.2018.01.011","article-title":"Association between habitual coffee consumption and metabolic syndrome in type 1 diabetes","volume":"28","author":"Stutz","year":"2018","journal-title":"Nutr Metabol Cardiovasc Dis"},{"key":"10.1016\/j.clnu.2021.04.011_bib66","doi-asserted-by":"crossref","first-page":"346","DOI":"10.4082\/kjfm.2017.38.6.346","article-title":"Relationship between coffee consumption and metabolic syndrome in Korean adults: data from the 2013- 2014 korea national health and nutrition examination survey","volume":"38","author":"Shin","year":"2017","journal-title":"Korean J Fam Med"},{"key":"10.1016\/j.clnu.2021.04.011_bib67","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1177\/1756283X16636765","article-title":"Coffee, caffeine and non-alcoholic fatty liver disease?","volume":"9","author":"Kennedy","year":"2015","journal-title":"Therap Adv Gastroenterol"},{"key":"10.1016\/j.clnu.2021.04.011_bib68","first-page":"2020","article-title":"Beneficial effects of coffee in non-alcoholic fatty liver disease: a narrative review","author":"Calabr\u00f2","year":"2020","journal-title":"Hepatoma Res"},{"key":"10.1016\/j.clnu.2021.04.011_bib69","doi-asserted-by":"crossref","first-page":"5597","DOI":"10.1021\/jf904062c","article-title":"Coffee and caffeine ameliorate hyperglycemia, fatty liver, and inflammatory adipocytokine expression in spontaneously diabetic KK-Ay mice","volume":"58","author":"Yamauchi","year":"2010","journal-title":"J\u00a0Agric Food Chem"},{"key":"10.1016\/j.clnu.2021.04.011_bib70","doi-asserted-by":"crossref","DOI":"10.1017\/jns.2019.10","article-title":"Coffee prevents fatty liver disease induced by a high-fat diet by modulating pathways of the gut-liver axis","author":"Vitaglione","year":"2019","journal-title":"J\u00a0Nutr Sci"},{"key":"10.1016\/j.clnu.2021.04.011_bib71","article-title":"Caffeine inhibits the activation of hepatic stellate cells induced by acetaldehyde via adenosine A2A receptor mediated by the cAMP\/PKA\/SRC\/ERK1\/2\/P38 MAPK signal pathway","volume":"9","author":"Wang","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.clnu.2021.04.011_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2018.101092","article-title":"Consumption of decaffeinated coffee protects against the development of early non-alcoholic steatohepatitis: role of intestinal barrier function","volume":"21","author":"Brandt","year":"2019","journal-title":"Redox Biol"},{"key":"10.1016\/j.clnu.2021.04.011_bib73","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2018.01399","article-title":"Geniposide and chlorogenic acid combination ameliorates non-alcoholic steatohepatitis involving the protection on the gut barrier function in mouse induced by high-fat diet","volume":"9","author":"Peng","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.clnu.2021.04.011_bib74","first-page":"287","article-title":"Chlorogenic acid alleviates autophagy and insulin resistance by suppressing JNK pathway in a rat model of nonalcoholic fatty liver disease","volume":"43","author":"Yan","year":"2018","journal-title":"J\u00a0Biosci"},{"key":"10.1016\/j.clnu.2021.04.011_bib75","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.bcp.2019.04.018","article-title":"Telmisartan and\/or chlorogenic acid attenuates fructose-induced non-alcoholic fatty liver disease in rats: implications of cross-talk between angiotensin, the sphingosine kinase\/sphingoine-1-phosphate pathway, and TLR4 receptors","volume":"164","author":"Alqarni","year":"2019","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.clnu.2021.04.011_bib76","doi-asserted-by":"crossref","DOI":"10.3390\/nu9010056","article-title":"Coffee intake is associated with a lower liver stiffness in patients with non-alcoholic fatty liver disease, hepatitis C, and hepatitis B","volume":"9","author":"Hodge","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.clnu.2021.04.011_bib77","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jhep.2017.03.013","article-title":"Coffee and herbal tea consumption is associated with lower liver stiffness in the general population: the Rotterdam study","volume":"67","author":"Alferink","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.clnu.2021.04.011_bib78","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1111\/liv.12379","article-title":"Coffee consumption in NAFLD patients with lower insulin resistance is associated with lower risk of severe fibrosis","volume":"34","author":"Bambha","year":"2014","journal-title":"Liver Int"},{"key":"10.1016\/j.clnu.2021.04.011_bib79","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.jhep.2012.07.014","article-title":"Regular coffee but not espresso drinking is protective against fibrosis in a cohort mainly composed of morbidly obese European women with NAFLD undergoing bariatric surgery","volume":"57","author":"Anty","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.clnu.2021.04.011_bib80","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1007\/s10620-010-1143-3","article-title":"Protective role of coffee in non-alcoholic fatty liver disease (NAFLD)","volume":"55","author":"Catalano","year":"2010","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.clnu.2021.04.011_bib81","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/1756283X15593700","article-title":"Association between caffeine consumption and nonalcoholic fatty liver disease: a systemic review and meta-analysis","volume":"9","author":"Shen","year":"2016","journal-title":"Therap Adv Gastroenterol"},{"key":"10.1016\/j.clnu.2021.04.011_bib82","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1365-2036.2011.04916.x","article-title":"Caffeine is protective in patients with non-alcoholic fatty liver disease","volume":"35","author":"Birerdinc","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clnu.2021.04.011_bib83","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.cgh.2017.02.038","article-title":"Coffee drinking and alcoholic and nonalcoholic fatty liver diseases and viral hepatitis in the multiethnic cohort","volume":"15","author":"Setiawan","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.clnu.2021.04.011_bib84","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/hep.24731","article-title":"Association of coffee and caffeine consumption with fatty liver disease, nonalcoholic steatohepatitis, and degree of hepatic fibrosis","volume":"55","author":"Molloy","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.clnu.2021.04.011_bib85","doi-asserted-by":"crossref","DOI":"10.3390\/nu10010089","article-title":"Coffee intake and liver steatosis: a population study in a mediterranean area","volume":"10","author":"Veronese","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.clnu.2021.04.011_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctim.2019.102290","article-title":"Effect of green coffee extract supplementation on serum adiponectin concentration and lipid profile in patients with non-alcoholic fatty liver disease: a randomized, controlled trial","volume":"49","author":"Hosseinabadi","year":"2020","journal-title":"Compl Ther Med"},{"key":"10.1016\/j.clnu.2021.04.011_bib87","doi-asserted-by":"crossref","DOI":"10.5812\/hepatmon.45609","article-title":"Effects of green coffee bean extract supplementation on patients with non-alcoholic fatty liver disease: a randomized clinical trial","volume":"17","author":"Shahmohammadi","year":"2017","journal-title":"Hepat Mon"},{"key":"10.1016\/j.clnu.2021.04.011_bib88","doi-asserted-by":"crossref","first-page":"8109","DOI":"10.1021\/jf804025c","article-title":"Polyphenols chemistry of tea and coffee: a century of progress","volume":"57","author":"Wang","year":"2009","journal-title":"J\u00a0Agric Food Chem"},{"key":"10.1016\/j.clnu.2021.04.011_bib89","doi-asserted-by":"crossref","first-page":"989","DOI":"10.3892\/ijmm.2013.1503","article-title":"Green tea with high-density catechins improves liver function and fat infiltration in non-alcoholic fatty liver disease (NAFLD) patients: a double-blind placebo-controlled study","volume":"32","author":"Sakata","year":"2013","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.clnu.2021.04.011_bib90","doi-asserted-by":"crossref","DOI":"10.7860\/JCDR\/2019\/35236.12986","article-title":"Therapeutic effects of green tea on nonalcoholic fatty liver disease in 10-16-year-old children","author":"Rostampour","year":"2019","journal-title":"J\u00a0Clin Diagn Res"},{"key":"10.1016\/j.clnu.2021.04.011_bib91","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/j.dsx.2019.03.021","article-title":"The effects of green tea on lipid metabolism and its potential applications for obesity and related metabolic disorders - an existing update","volume":"13","author":"Dinh","year":"2019","journal-title":"Diabetes Metab Syndr Clin Res Rev"},{"key":"10.1016\/j.clnu.2021.04.011_bib92","first-page":"323","article-title":"Green tea extract protects leptin-deficient, spontaneously obese mice from hepatic steatosis and injury","volume":"138","author":"Bruno","year":"2008","journal-title":"J\u00a0Nutr"},{"key":"10.1016\/j.clnu.2021.04.011_bib93","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jnutbio.2016.12.007","article-title":"Green tea extract treatment reduces NF\u03baB activation in mice with diet-induced nonalcoholic steatohepatitis by lowering TNFR1 and TLR4 expression and ligand availability","volume":"41","author":"Li","year":"2017","journal-title":"J\u00a0Nutr Biochem"},{"key":"10.1016\/j.clnu.2021.04.011_bib94","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.201900811","article-title":"Green tea extract treatment in obese mice with nonalcoholic steatohepatitis restores the hepatic metabolome in association with limiting endotoxemia-TLR4-nf?b-mediated inflammation","volume":"63","author":"Sasaki","year":"2019","journal-title":"Mol Nutr Food Res"},{"key":"10.1016\/j.clnu.2021.04.011_bib95","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3164\/jcbn.08-256","article-title":"Beneficial effects of fermented green tea extract in a rat model of non-alcoholic steatohepatitis","volume":"44","author":"Nakamoto","year":"2009","journal-title":"J\u00a0Clin Biochem Nutr"},{"key":"10.1016\/j.clnu.2021.04.011_bib96","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.201700483","article-title":"Potential biological effects of (-)-Epigallocatechin-3-gallate on the treatment of nonalcoholic fatty liver disease","volume":"62","author":"Chen","year":"2018","journal-title":"Mol Nutr Food Res"},{"key":"10.1016\/j.clnu.2021.04.011_bib97","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/sj.ijo.0802141","article-title":"Beneficial effects of tea catechins on diet-induced obesity: stimulation of lipid catabolism in the liver","volume":"26","author":"Murase","year":"2002","journal-title":"Int J Obes"},{"key":"10.1016\/j.clnu.2021.04.011_bib98","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.phymed.2004.07.001","article-title":"Epigallocatechin gallate (EGCG) (TEAVIGOTM) does not impair nonhaem-iron absorption in man","volume":"12","author":"Ullmann","year":"2005","journal-title":"Phytomedicine"},{"key":"10.1016\/j.clnu.2021.04.011_bib99","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.hepres.2006.08.003","article-title":"Effect of iron reduction by phlebotomy in Japanese patients with nonalcoholic steatohepatitis: a pilot study","volume":"36","author":"Sumida","year":"2006","journal-title":"Hepatol Res"},{"key":"10.1016\/j.clnu.2021.04.011_bib100","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.bbrc.2011.11.102","article-title":"Theaflavin attenuates ischemia-reperfusion injury in a mouse fatty liver model","volume":"417","author":"Luo","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.clnu.2021.04.011_bib101","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1002\/ptr.6130","article-title":"Green tea as a safe alternative approach for nonalcoholic fatty liver treatment: a systematic review and meta-analysis of clinical trials","volume":"32","author":"Mansour-Ghanaei","year":"2018","journal-title":"Phyther Res"},{"key":"10.1016\/j.clnu.2021.04.011_bib102","first-page":"14993","article-title":"Green tea in non-alcoholic fatty liver disease","author":"Tabatabaee","year":"2017","journal-title":"A\u00a0Double Blind Randomized Clinical Trial"},{"key":"10.1016\/j.clnu.2021.04.011_bib103","first-page":"1","article-title":"The effect of green tea extract supplementation on liver enzymes in patients with nonalcoholic fatty liver disease","author":"Pezeshki","year":"2015","journal-title":"Int J Prev Med"},{"key":"10.1016\/j.clnu.2021.04.011_bib104","first-page":"931","article-title":"Therapeutic benefits of green tea extract on various parameters in non-alcoholic fatty liver disease patients","volume":"33","author":"Hussain","year":"2017","journal-title":"Pakistan J Med Sci"},{"key":"10.1016\/j.clnu.2021.04.011_bib105","doi-asserted-by":"crossref","DOI":"10.21037\/tgh.2019.09.02","article-title":"Effect of alcohol consumption on nonalcoholic fatty liver disease","volume":"4","author":"Weng","year":"2019","journal-title":"Transl Gastroenterol Hepatol"},{"key":"10.1016\/j.clnu.2021.04.011_bib106","first-page":"2104","article-title":"Association between alcohol consumption and metabolic syndrome in a community-based cohort of Korean adults","volume":"23","author":"Kim","year":"2017","journal-title":"Med Sci Mon Int Med J Exp Clin Res"},{"key":"10.1016\/j.clnu.2021.04.011_bib107","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-016-0721-4","article-title":"Differing association of alcohol consumption with different stroke types: a systematic review and meta-analysis","volume":"14","author":"Larsson","year":"2016","journal-title":"BMC Med"},{"key":"10.1016\/j.clnu.2021.04.011_bib108","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1007\/s00394-019-02017-1","article-title":"Moderate chronic ethanol consumption exerts beneficial effects on nonalcoholic fatty liver in mice fed a high-fat diet: possible role of higher formation of triglycerides enriched in monounsaturated fatty acids","volume":"59","author":"Bucher","year":"2020","journal-title":"Eur J Nutr"},{"key":"10.1016\/j.clnu.2021.04.011_bib109","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s00394-015-0929-7","article-title":"Moderate alcohol consumption diminishes the development of non-alcoholic fatty liver disease (NAFLD) in ob\/ob mice","volume":"55","author":"Kanuri","year":"2016","journal-title":"Eur J Nutr"},{"key":"10.1016\/j.clnu.2021.04.011_bib110","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.jhep.2012.03.024","article-title":"Modest alcohol consumption is associated with decreased prevalence of steatohepatitis in patients with non-alcoholic fatty liver disease (NAFLD)","volume":"57","author":"Dunn","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.clnu.2021.04.011_bib111","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1136\/gutjnl-2013-305718","article-title":"Modest alcohol consumption decreases the risk of nonalcoholic fatty liver disease: a meta-analysis of 43 175 individuals","volume":"63","author":"Sookoian","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.clnu.2021.04.011_bib112","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0191026","article-title":"Light alcohol consumption has the potential to suppress hepatocellular injury and liver fibrosis in non-alcoholic fatty liver disease","volume":"13","author":"Yamada","year":"2018","journal-title":"PloS One"},{"key":"10.1016\/j.clnu.2021.04.011_bib113","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/192543","article-title":"Toll-like receptor signaling and liver fibrosis","author":"Aoyama","year":"2010","journal-title":"Gastroenterol Res Pract"},{"key":"10.1016\/j.clnu.2021.04.011_bib114","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/hep.30226","article-title":"Effect of alcohol consumption on survival in nonalcoholic fatty liver disease: a national prospective cohort study","volume":"70","author":"Hajifathalian","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.clnu.2021.04.011_bib115","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/j.cgh.2018.01.026","article-title":"Among patients with nonalcoholic fatty liver disease, modest alcohol use is associated with less improvement in histologic steatosis and steatohepatitis","volume":"16","author":"Ajmera","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.clnu.2021.04.011_bib116","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.jhepr.2019.10.008","article-title":"Lifestyle modification in NAFLD\/NASH: facts and figures","volume":"1","author":"Hallsworth","year":"2019","journal-title":"JHEP Reports"},{"key":"10.1016\/j.clnu.2021.04.011_bib117","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/17446651.2020.1740588","article-title":"Nonalcoholic fatty liver disease, insulin resistance, and sweeteners: a literature review","volume":"15","author":"Kakleas","year":"2020","journal-title":"Expet Rev Endocrinol Metabol"},{"key":"10.1016\/j.clnu.2021.04.011_bib118","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1007\/s00394-019-01996-5","article-title":"Non-nutritive sweeteners and their association with the metabolic syndrome and non-alcoholic fatty liver disease: a review of the literature","volume":"58","author":"Green","year":"2019","journal-title":"Eur J Nutr"},{"key":"10.1016\/j.clnu.2021.04.011_bib119","doi-asserted-by":"crossref","DOI":"10.3390\/nu12030825","article-title":"Dietary factors in relation to liver fat content: a\u00a0cross-sectional study","volume":"12","author":"Watzinger","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.clnu.2021.04.011_bib120","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/apt.13716","article-title":"Editorial: dark chocolate may improve NAFLD and metabolic syndrome by reducing oxidative stress","volume":"44","author":"Malhi","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clnu.2021.04.011_bib121","doi-asserted-by":"crossref","first-page":"11406","DOI":"10.1039\/C9RA00669A","article-title":"Blond and blood juice supplementation in high fat diet fed mice: effect on antioxidant status and DDAH\/ADMA pathway","volume":"9","author":"Sorrenti","year":"2019","journal-title":"RSC Adv"},{"key":"10.1016\/j.clnu.2021.04.011_bib122","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1590\/0001-3765202020191230","article-title":"Effects of grape juice, red wine and resveratrol on liver parameters of rat submitted high-fat diet","volume":"92","author":"Bed\u00ea","year":"2020","journal-title":"An Acad Bras Cienc"},{"key":"10.1016\/j.clnu.2021.04.011_bib123","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.3390\/nu10091153","article-title":"Nutraceutical approach to non-alcoholic fatty liver disease (NAFLD): the available clinical evidence","volume":"10","author":"Cicero","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.clnu.2021.04.011_bib124","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1111\/dom.13324","article-title":"Resveratrol effect on patients with non-alcoholic fatty liver disease: a matter of dose and treatment length","volume":"20","author":"Fogacci","year":"2018","journal-title":"Diabetes Obes Metabol"},{"key":"10.1016\/j.clnu.2021.04.011_bib125","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1024\/0300-9831\/a000292","article-title":"Effects of pomegranate and orange juice on antioxidant status in non-alcoholic fatty liver disease patients: a randomized clinical trial","volume":"85","author":"Ekhlasi","year":"2015","journal-title":"Int J Vitam Nutr Res"},{"key":"10.1016\/j.clnu.2021.04.011_bib126","doi-asserted-by":"crossref","first-page":"199","DOI":"10.34297\/AJBSR.2019.05.000910","article-title":"The intake of Aronia melanocarpa fruits and juice has great potential for prevention of socially significant diseases","volume":"5","author":"Boncheva","year":"2019","journal-title":"Am J Biomed Sci Res"}],"container-title":["Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S026156142100203X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S026156142100203X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:58:36Z","timestamp":1759366716000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S026156142100203X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":126,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S026156142100203X"],"URL":"https:\/\/doi.org\/10.1016\/j.clnu.2021.04.011","relation":{},"ISSN":["0261-5614"],"issn-type":[{"value":"0261-5614","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beverages and Non-alcoholic fatty liver disease (NAFLD): Think before you drink","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnu.2021.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.","name":"copyright","label":"Copyright"}]}}